Loading
Latest filing published 30 Jul 2026 for Aytu Biopharma, INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Vivian H. Liu is a declared insider of Aytu Biopharma, Inc (board member), with filings sourced from SEC (Form 4). The record holds 7 filings, for trades running from 1 July 2022 to 28 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 30 July 2026, the filings show a share grant in Aytu Biopharma, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations